Showing 1,921 - 1,940 results of 102,664 for search '(( 5 ((c decrease) OR (a decrease)) ) OR ( 5 ((nm decrease) OR (mean decrease)) ))', query time: 1.68s Refine Results
  1. 1921

    OSU-HDAC-44 decreased RhoA activity via srGAP1 induction, leading to F-actin dysregulation. by Yen-An Tang (187547)

    Published 2010
    “…<p>(<b>A</b>) Chromatin-immunoprecipitation-PCR analyses confirmed that treatment with 2.5 µM OSU-HDAC-44 for 2 h induced acetylation of histone H3 (H3K9K14Ac) in the promoter region of <i>srGAP1</i>, <i>NR4A1</i> and <i>FOXO4</i> genes. …”
  2. 1922
  3. 1923
  4. 1924
  5. 1925
  6. 1926
  7. 1927
  8. 1928

    Efficacy and Acceptability of Glycemic Control of Glucagon-Like Peptide-1 Receptor Agonists among Type 2 Diabetes: A Systematic Review and Network Meta-Analysis by Zhixia Li (2736331)

    Published 2016
    “…Dulaglutide, exenatide long-acting release (exe_lar), liraglutide and taspoglutide had significant lowering effect when compared with sitagliptin (HbA1c<7.0%) and insulin (HbA1c<6.5%). Finally, according to SUCRAs, placebo, thiazolidinediones and albiglutide had the best decrease effect on hypoglycemia; sulphanylureas, sitagliptin and insulin decrease the incidence of treatment discontinuation most; exe_lar and dulaglutide had the highest impact on glycemic level among 13 treatments.…”
  9. 1929
  10. 1930
  11. 1931
  12. 1932
  13. 1933
  14. 1934
  15. 1935
  16. 1936
  17. 1937
  18. 1938
  19. 1939
  20. 1940